Disease | differentiated thyroid carcinoma |
Symptom | C0029896|ent disease |
Sentences | 3 |
PubMedID- 21936380 | Serum thyroglobulin (tg) is primarily used as a tumor marker to detect the recurrent or persistent disease in patients with differentiated thyroid carcinomas. |
PubMedID- 22791600 | Fluorodeoxyglucose-positron emission tomography (fdg-pet)/computed tomography (ct) is able to localize persistent or recurrent disease in differentiated thyroid carcinoma (dtc). |
PubMedID- 20017617 | Conclusion: in the diagnosis of recurrent disease in patients with differentiated thyroid carcinoma and low tg level, the sensitivity of rhtsh-stimulated pet/ct-fdg seems to be low and no correlation was observed between pet/ct-fdg findings and tg level. |
Page: 1